Development of a Novel Anti-CD44 Variant 8 Monoclonal Antibody C(44)Mab-94 against Gastric Carcinomas

Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC with peritoneal metastasis exhibits a poor prognosis due to the lack of effective therapy. A comprehensive analysis of malignant ascites identified the genomic alterations and significant amplifications of cancer d...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Hiroyuki, Goto, Nohara, Tanaka, Tomohiro, Ouchida, Tsunenori, Kaneko, Mika K., Kato, Yukinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366929/
https://www.ncbi.nlm.nih.gov/pubmed/37489367
http://dx.doi.org/10.3390/antib12030045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366929/
https://www.ncbi.nlm.nih.gov/pubmed/37489367
http://dx.doi.org/10.3390/antib12030045

Ejemplares similares